Skip to main content
LON:ALS

Altus Strategies Share Forecast, Price & News

GBX 63.70
+3.70 (+6.17 %)
(As of 05/14/2021 09:31 AM ET)
Add
Compare
Today's Range
60
63.70
50-Day Range
63.25
76.50
52-Week Range
27
94.99
Volume10,343 shs
Average Volume51,209 shs
Market Capitalization£51.21 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ALS News and Ratings via Email

Sign-up to receive the latest news and ratings for Altus Strategies and its competitors with MarketBeat's FREE daily newsletter.


Altus Strategies logo

About Altus Strategies

Altus Strategies plc, together its subsidiaries, discovers, acquires, explores for, and develops mineral properties in Africa. The company primarily explores for gold, bauxite, copper, iron ore, zinc, lead, silver, tin, and tungsten deposits. It has a portfolio of projects, including Korali Sud (Diba) gold project and Lakanfla gold project located in Western Mali; Tabakorole gold project and Pitiangoma Est gold project located in Southern Mali; Wadi Jundi gold project, Bakriyah gold project, Abu Diwan gold project, Wadi Dubur gold project located in Egypt; Laboum gold project located in Northern Cameroon; Bikoula iron ore project located in Southern Cameroon; Agdz copper-silver project, Takzim copper-zinc project, Zaer copper project, and Ammas zinc-lead project located in Central Morocco; Igzougza copper-silver project, Azrar copper project, and Tata copper project located in Western Morocco; Daro copper-gold project and Zager copper-gold project located in Northern Ethiopia; and Leopard Rock gold prospect located in Western Liberia. Altus Strategies plc was incorporated in 2007 and is based in Didcot, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Industrial Metals & Minerals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+44-1235-511767
Employees28
Year FoundedN/A

Sales & Book Value

Annual Sales£287,708.00
Cash FlowGBX 9.51 per share
Book ValueGBX 16.70 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap£51.21 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.42 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Altus Strategies (LON:ALS) Frequently Asked Questions

What stocks does MarketBeat like better than Altus Strategies?

Wall Street analysts have given Altus Strategies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Altus Strategies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Altus Strategies' stock price been impacted by Coronavirus (COVID-19)?

Altus Strategies' stock was trading at GBX 28.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ALS shares have increased by 123.5% and is now trading at GBX 63.70.
View which stocks have been most impacted by COVID-19
.

Who are Altus Strategies' key executives?

Altus Strategies' management team includes the following people:
  • Mr. Steven James Poulton BSC, MSc, MCSM, CEO & Exec. Director (Age 44, Pay $184.38k)
  • Mr. Martin John Keylock, CFO & Company Sec.
  • Mr. Matthew Roy Grainger, Exec. Director (Age 48, Pay $147.5k)
  • Mr. William Slater, VP of Operations
  • Ms. Sandra Naomi Bates, Gen. Counsel (Age 48)
  • Mr. David Lindsay Miles B.Sc., C.A., C.P.A., BSc. Geology, Adviser (Age 70)
  • Ms. Val Mitchell, Office & Fin. Mang.

Who are some of Altus Strategies' key competitors?

What other stocks do shareholders of Altus Strategies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Altus Strategies investors own include NewAge (NBEV), Johnson Controls International (JCI), Hurricane Energy (HRCXF), EyeGate Pharmaceuticals (EYEG), Bank of America (BAC) and Adient (ADNT).

What is Altus Strategies' stock symbol?

Altus Strategies trades on the London Stock Exchange (LON) under the ticker symbol "ALS."

How do I buy shares of Altus Strategies?

Shares of ALS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Altus Strategies' stock price today?

One share of ALS stock can currently be purchased for approximately GBX 63.70.

How much money does Altus Strategies make?

Altus Strategies has a market capitalization of £51.21 million and generates £287,708.00 in revenue each year.

How many employees does Altus Strategies have?

Altus Strategies employs 28 workers across the globe.

What is Altus Strategies' official website?

The official website for Altus Strategies is www.altus-strategies.com.

Where are Altus Strategies' headquarters?

Altus Strategies is headquartered at 14 Station Road, The Orchard Centre, DIDCOT, OX11 7LL, United Kingdom.

How can I contact Altus Strategies?

Altus Strategies' mailing address is 14 Station Road, The Orchard Centre, DIDCOT, OX11 7LL, United Kingdom. The company can be reached via phone at +44-1235-511767.


This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.